Logic‐Gated HSV‐TK/GCV Suicide Gene Circuit for Triple‐Negative Breast Cancer
Advanced Science · 2026
DOI: 10.1002/advs.202514749 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Shasha Tang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Thymidine Kinase, Genetic Therapy, Ganciclovir. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai, Nature Science Foundation of Chongqing, China.
Abstract (Originalsprache)
Triple‐negative breast cancer (TNBC) remains a major clinical challenge, owing to its molecular complexity, therapeutic resistance, and lack of specific druggable targets. The herpes simplex virus thymidine kinase/ganciclovir (HSV‐TK/GCV) suicide gene therapy system has shown promise in cancer treatment, but its clinical applicability is limited by off‐target cytotoxicity. Here, we developed a br east c a ncer‐specific s uicide gene circuit (BRAS) that integrates the screened cancer‐specific promoters RRM2 and MAFK with a microRNA specific to nontumor cells, utilizing the distinct molecular profiles of tumor and nontumor cells. This multi‐input logic gate circuit enables precise, specific expression of HSV‐TK in breast cancer cells with hardly expression in normal cell. We show that BRAS selectively induces apoptosis in patient‐derived TNBC cells while sparing normal cells. In two orthotopic breast cancer models, BRAS significantly suppressed tumor growth without affecting body weight or general health, underscoring its therapeutic potential. This approach intelligently combines molecular signals from both cancerous and healthy cells to precisely regulate therapeutic gene expression, making it a promising platform for the next‐generation cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
- Institute of Medical Technology, Shanxi Medical University, Taiyuan, Shanxi Province, China.
- Shanghai 411 Hospital, China RongTong Medical Healthcare Group Co. Ltd., 411 Hospital, School of Medicine, Shanghai University, Shanghai, China.
- Chongqing Key Laboratory of Precision Optics, Chongqing Institute of East China Normal University, Chongqing, China.
ORCID-Profile: Longliang Qiao, Meiyan Wang, Fengfeng Cai
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai
- Nature Science Foundation of Chongqing, China
- Young Scientists Fund of the National Natural Science Foundation of China
- Postdoctoral Fellowship Program
- China Postdoctoral Science Foundation
- Sixth Cycle Key Discipline Funding from Tongji Hospital, School of Medicine, Tongji University
- Tongji Hospital, School of Medicine, Tongji University
Zitieren
APA
Tang, S., Fang, Y., Jin, L., Liu, D., Liu, Y., Zheng, R., Yong, L., Wu, X., Qiao, L., Wang, M., & Cai, F. (2026). Logic‐Gated HSV‐TK/GCV Suicide Gene Circuit for Triple‐Negative Breast Cancer. Advanced Science. https://doi.org/10.1002/advs.202514749
Vancouver
Tang S, Fang Y, Jin L, Liu D, Liu Y, Zheng R, et al. Logic‐Gated HSV‐TK/GCV Suicide Gene Circuit for Triple‐Negative Breast Cancer. Advanced Science. 2026. doi:10.1002/advs.202514749
BibTeX
@article{Tang2026,
author = {Tang, Shasha and Fang, Yuan and Jin, Lingli and Liu, Dongyang and Liu, Yicheng and Zheng, Ruijia and Yong, Liyun and Wu, Xin and Qiao, Longliang and Wang, Meiyan and Cai, Fengfeng},
title = {Logic‐Gated HSV‐TK/GCV Suicide Gene Circuit for Triple‐Negative Breast Cancer},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202514749}
}
EUVIMED